Posterior reversible encephalopathy syndrome after rituximab infusion in neuromyelitis optica

Neurology

Volumn 74, Issue 18, 2010, Pages 1471-1473

  Sánchez Carteyron, Alejandro ^a   Alarcia, Raquel ^a   Ara, José Ramón ^a   Martín, Jesús ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; RITUXIMAB;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONFUSION; DROWSINESS; FEMALE; HUMAN; MYELOOPTIC NEUROPATHY; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; SYNDROME DELINEATION; VISUAL HALLUCINATION; VOMITING;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MAGNETIC RESONANCE IMAGING; NEUROMYELITIS OPTICA; NEUROTOXICITY SYNDROMES; SYNDROME;

EID: 77951854126     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181dc1af3     Document Type: Article

References (6)

1. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
2. Magaña SM, Matiello M, Pittock SJ, et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 2009;72:712-717.
3. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neu-romyelitis optica. Neurology 2006;66:1485-1489.
4. McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007;189:904-912.
5. Matsushita T, Isobe N, Matsuoka T, et al. Extensive vaso-genic edema of anti-aquaporin-4 antibody-related brain lesions. Mult Scler 2009;15:1113-1117.
6. Mavragani CP, Vlachoyiannopoulos PG, Kosmas N, Bole-tis I, Tzioufas AG, Voulgarelis M. A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion. Rheumatology 2004;43:1450-1451.